"The greatest wealth is health."         - Virgil

      Advertisement

Our Experts answered these questions:

My wife has arthritis,quite severe. if she sustains a bruise or a cut the results last for weeks or even months. she bruises badly with the slightest...
I was up last night having to use the bathroom with diarrhea for about an hour. This morning i woke up and i felt like i was going to throw up and i h...
Do You Have a Health Question? Ask Our Experts!

Vaccine Safety

Menu

• Home
• Ask our Experts about KEPPRA
• Ask Community about KEPPRA
• KEPPRA Usage
• Patients Wiki
• Share Your Health Story
• Take a Survey
• Health Blogs

More Resources

• Federal Food and Drug Administration
• Hospital Quality Reports
• Home Care Quality

KEPPRA Safety Questions, KEPPRA Answers

More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about KEPPRA. Our extensive database of KEPPRA adverse events and KEPPRA warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements

Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about KEPPRA

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet

Type your question here

 letters left

KEPPRA Safety Reports

Total KEPPRA reports: 688.
KEPPRA FDA safety alerts: 2003 .
Reported deaths: 84    Reported hospitalizations: 287.
Take KEPPRA Side Effects Survey or Share Your KEPPRA Story. KEPPRA Usage.

Showing 1-75 of 688 Next >

Health Professional from BULGARIA reported KEPPRA problem on Jan 31, 2007. Female patient, 20 years of age, weighting 138.9 lb, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: abortion induced, pregnancy. KEPPRA dosage: 1500 MG 2/D PO. During the same period patient was treated with DEPAKENE. Patient recovered.

KEPPRA problem was reported by a Physician from HUNGARY on Feb 01, 2007. Female patient, 28 years of age, weighting 174.2 lb, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: abortion threatened, caesarean section, convulsion. KEPPRA dosage: 1500 MG PO. During the same period patient was treated with INSULIN HUMULIN, HUMULIN N, FOLIC ACID, LAXATIVES. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from GERMANY reported KEPPRA problem on Jan 31, 2007. Female patient, 54 years of age, was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: conversion disorder, hostility, screaming, unevaluable event. KEPPRA dosage: 1000 MG 2/D. Patient was hospitalized. Patient recovered.

KEPPRA problem was reported by a Health Professional from UNITED STATES on Feb 20, 2007. Female patient, weighting 220.0 lb, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: anger, crying, thinking abnormal. KEPPRA dosage: unknown. Patient recovered.

Health Professional from FRANCE reported KEPPRA problem on Feb 12, 2007. Female patient, 45 years of age, was diagnosed with autoimmune thyroiditis, partial seizures and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: constipation, subileus, vomiting. KEPPRA dosage: 400 MG PER DAY. During the same period patient was treated with THYROID HORMONES, TEGRETOL. Patient recovered.

KEPPRA problem was reported by a Consumer or non-health professional from GERMANY on Feb 01, 2007. Female patient, 80 years of age, was diagnosed with status epilepticus and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: loss of consciousness. KEPPRA dosage: unknown. During the same period patient was treated with BENZODIAZEPINES. Patient died.

Physician from GERMANY reported KEPPRA problem on Feb 02, 2007. Male patient, 18 years of age, weighting 209.4 lb, was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: condition aggravated, myoclonus, status epilepticus. KEPPRA dosage: 500 MG 2/D PO. During the same period patient was treated with TOPIRAMATE. Patient was hospitalized. Patient recovered.

KEPPRA problem was reported by a Physician from GERMANY on Feb 02, 2007. Male patient, child 6 years of age, was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: respiratory failure. KEPPRA dosage: unknown. During the same period patient was treated with LUMINAL. Patient died.

Physician from UNITED KINGDOM reported KEPPRA problem on Feb 02, 2007. Male patient, 25 years of age, was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: epilepsy. KEPPRA dosage: unknown. Patient died.

KEPPRA problem was reported by a Physician from GERMANY on Feb 01, 2007. Male patient, 77 years of age, was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: coma. KEPPRA dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from GERMANY reported KEPPRA problem on Feb 02, 2007. Male patient, 18 years of age, weighting 209.4 lb, was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: status epilepticus. KEPPRA dosage: 500 MG 2/D PO. During the same period patient was treated with TOPIRAMATE. Patient was hospitalized. Patient recovered.

KEPPRA problem was reported by a Physician from GERMANY on Feb 02, 2007. Male patient, child 6 years of age, was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: respiratory failure. KEPPRA dosage: unknown. During the same period patient was treated with LUMINAL. Patient died.

Physician from UNITED KINGDOM reported KEPPRA problem on Feb 02, 2007. Male patient, 25 years of age, was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: epilepsy. KEPPRA dosage: unknown. Patient died.

KEPPRA problem was reported by a Consumer or non-health professional from GERMANY on Feb 05, 2007. Female patient, 31 years of age, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: respiratory depression. KEPPRA dosage: unknown. During the same period patient was treated with CARBAMAZEPINE. Patient was hospitalized. Patient recovered.

Physician from NETHERLANDS reported KEPPRA problem on Feb 06, 2007. Male patient, child 12 years of age, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: ileus, large intestine perforation. KEPPRA dosage: 800 MG 2/D. During the same period patient was treated with LAMOTRIGINE, CLONAZEPAM, OXCARBAZEPINE. Patient died on 12/27/2006.

KEPPRA problem was reported by a Physician from PORTUGAL on Feb 08, 2007. Female patient, 14 years of age, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: alopecia, neutropenia. KEPPRA dosage: 750 MG/D PO. Patient recovered.

Physician from NETHERLANDS reported KEPPRA problem on Feb 05, 2007. Female patient was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: condition aggravated, convulsion, status epilepticus, stevens-johnson syndrome. KEPPRA dosage: 500 MG 2/D. During the same period patient was treated with DEPAKENE, DIPHANTOINE. Patient was hospitalized. Patient recovered.

KEPPRA problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 05, 2007. Male patient, 29 years of age, was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: treatment noncompliance. KEPPRA dosage: 750 MG 2/D PO. During the same period patient was treated with VALPROATE. Patient died on 09/06/2006.

Physician from UNITED STATES reported KEPPRA problem on Feb 05, 2007. Female patient, 31 years of age, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: caesarean section, vasa praevia. KEPPRA dosage: 2000 MG/D. During the same period patient was treated with PRENATAL VITAMINS, FOLIC ACID. Patient recovered.

KEPPRA problem was reported by a Health Professional from GERMANY on Feb 08, 2007. Male patient, 60 years of age, was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: nephritis interstitial. KEPPRA dosage: unknown. Patient recovered.

Physician from GERMANY reported KEPPRA problem on Feb 06, 2007. Female patient was diagnosed with partial seizures and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: impulsive behaviour, psychomotor retardation, salivary hypersecretion. KEPPRA dosage: unknown. During the same period patient was treated with VALPROATE. Patient was hospitalized. Patient recovered.

KEPPRA problem was reported by a Physician from UNITED STATES on Feb 07, 2007. Female patient, 42 years of age, was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: platelet count decreased. KEPPRA dosage: 500 MG 2/D IV. Patient recovered.

Health Professional from GERMANY reported KEPPRA problem on Feb 12, 2007. Male patient, 75 years of age, was diagnosed with epilepsy, hypercholesterolaemia and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: erythema, folate deficiency, hyponatraemia, pruritus, skin reaction, vitamin b12 deficiency. KEPPRA dosage: 250 MG 2/D. During the same period patient was treated with LOCOL, DELEX PLUS, BELOC, VITAMIN B12. Patient was hospitalized. Patient recovered.

KEPPRA problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 12, 2007. Male patient, 36 years of age, weighting 175.4 lb, was diagnosed with convulsion and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: aphasia, dizziness, feeling drunk, gait disturbance, speech disorder. KEPPRA dosage: 500 MG 2/D PO. During the same period patient was treated with TYLENOL, ADVIL, DARVOCET. Patient recovered.

Health Professional from UNITED STATES reported KEPPRA problem on Feb 12, 2007. Female patient was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: caesarean section, convulsion, partial seizures, pregnancy. KEPPRA dosage: 1000 MG. During the same period patient was treated with TEGRETOL, KLONOPIN. Patient recovered.

KEPPRA problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 12, 2007. Male patient was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: apgar score low, caesarean section, cystitis, enterobacter infection, hydronephrosis, klebsiella infection, oral intake reduced, phimosis. KEPPRA dosage: 2000 MG TRP. During the same period patient was treated with TEGRETOL, CLONAZEPAM. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported KEPPRA problem on Feb 12, 2007. Female patient, 33 years of age, weighting 104.7 lb, was diagnosed with convulsion and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, condition aggravated, headache, hypersensitivity, leukopenia, lip disorder, lymphopenia. KEPPRA dosage: unknown. During the same period patient was treated with LAMICTAL, IMITREX, LEXAPRO, RELAFEN. Patient was hospitalized. Patient recovered.

KEPPRA problem was reported by a Physician from GERMANY on Feb 13, 2007. Female patient, 39 years of age, weighting 127.9 lb, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: agitation, convulsion, delusional disorder, persecutory type, irritability, psychotic disorder, weight decreased. KEPPRA dosage: 250 MG 2/D PO. During the same period patient was treated with NEURONTIN, CARBAMAZEPINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from GERMANY reported KEPPRA problem on Feb 13, 2007. Female patient, 39 years of age, was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: autoimmune hepatitis, cardiac arrest, hepatocellular damage, hepatotoxicity, hyponatraemia, polyuria, sinus arrest, supraventricular extrasystoles. KEPPRA dosage: 500 MG /D PO. During the same period patient was treated with PHENYTOIN, VALPROATE. Patient recovered.

KEPPRA problem was reported by a Physician from GERMANY on Feb 14, 2007. Female patient, 66 years of age, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: photosensitivity reaction, rash. KEPPRA dosage: 500 MG 3/D. During the same period patient was treated with UNACID, TRILEPTAL, RAMIPRIL, AMLODIPINE, PANTOZOL, BELOC, BEKAWAN, BERODUAL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from FRANCE reported KEPPRA problem on Feb 14, 2007. Male patient, 52 years of age, was diagnosed with status epilepticus and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: condition aggravated, convulsion, status epilepticus. KEPPRA dosage: unknown. During the same period patient was treated with PENTOTHAL, DEPAKENE, RIVOTRIL, FOSPHENYTOIN. Patient died on 01/24/2007.

KEPPRA problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 14, 2007. Male patient, 40 years of age, weighting 149.9 lb, was diagnosed with convulsion prophylaxis, meningitis bacterial and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: anaemia, gastric ulcer, haemodialysis, influenza, nausea, pharyngeal oedema, renal failure, stevens-johnson syndrome, stress ulcer. KEPPRA dosage: 1000 MG 2/D PO. During the same period patient was treated with TROVAFLOXINE, CEFEPIME. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported KEPPRA problem on Feb 15, 2007. Male patient was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: premature baby. KEPPRA dosage: 3500 MG/D TRP. During the same period patient was treated with TRILEPTAL, PRENATAL VITAMINS. Patient recovered.

KEPPRA problem was reported by a Physician from UNITED STATES on Feb 15, 2007. Female patient, 32 years of age, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: hellp syndrome, pre-eclampsia, premature labour. KEPPRA dosage: 3500 MG /D PO. During the same period patient was treated with TRILEPTAL. Patient recovered.

Health Professional from UNITED STATES reported KEPPRA problem on Feb 15, 2007. Male patient, weighting 5.60 lb, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: dacryostenosis congenital. KEPPRA dosage: 3000 MG /D TRP. During the same period patient was treated with AMBIEN, KENALOG, PRENATAL VITAMINS, PHENERGAN, ALBUTEROL, METOCLOPRAMIDE, PROZAC, FERROUS SULPHATE. Patient recovered.

KEPPRA problem was reported by a Consumer or non-health professional from GERMANY on Feb 15, 2007. Female patient was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: unintended pregnancy. KEPPRA dosage: 500 MG 2/D. Patient recovered.

Physician from UNITED STATES reported KEPPRA problem on Mar 06, 2007. Male patient was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: atrial septal defect, heart disease congenital, patent ductus arteriosus, urinary tract malformation, ventricular hypertrophy. KEPPRA dosage: 1000 MG BID PO. Patient recovered.

KEPPRA problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 16, 2007. Female patient, 52 years of age, was diagnosed with epilepsy, urinary tract infection and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: body temperature increased, convulsion, dehydration, fall, feeding tube complication, hypersensitivity, hypotension, incorrect dose administered. KEPPRA dosage: 1500 MG 2/D PO. During the same period patient was treated with LEVAQUIN, DILANTIN. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported KEPPRA problem on Feb 16, 2007. Female patient, 23 years of age, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis. KEPPRA dosage: 1000 MG /D. During the same period patient was treated with FOLIC ACID, PHENYTOIN. Patient recovered.

KEPPRA problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 20, 2007. Female patient, 63 years of age, was diagnosed with convulsion, dementia alzheimer's type and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: agitation, convulsion, dementia alzheimer's type, disease progression, lethargy, nausea, somnolence, urinary tract infection. KEPPRA dosage: unknown. During the same period patient was treated with NAMENDA, ARICEPT, DILANTIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported KEPPRA problem on Mar 08, 2007. Male patient, 59 years of age, weighting 184.0 lb, was diagnosed with pain and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, aggression. KEPPRA dosage: unknown. During the same period patient was treated with ENALAPRIL MALEATE, METOPROLOL SUCCINATE, FELODIPINE. Patient recovered.

KEPPRA problem was reported by a Health Professional from UNITED STATES on Mar 13, 2007. Female patient, 14 years of age, weighting 185.0 lb, was diagnosed with convulsion and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: completed suicide. KEPPRA dosage: 250 MG, BID. During the same period patient was treated with TRILEPTAL. Patient died on 01/19/2007.

Consumer or non-health professional from GERMANY reported KEPPRA problem on Feb 26, 2007. Female patient was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: convulsion, fatigue. KEPPRA dosage: unknown. During the same period patient was treated with VALPROATE, MONOMACK, NEXIUM, METOPROLOL SUCCINATE, THIAMINE, VITAMIN B6. Patient was hospitalized. Patient recovered.

KEPPRA problem was reported by a Consumer or non-health professional from FRANCE on Feb 26, 2007. Female patient, 76 years of age, was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: haemoglobin decreased, platelet count decreased, white blood cell count decreased. KEPPRA dosage: 1000 MG 1/D PO. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported KEPPRA problem on Feb 26, 2007. Female patient, 24 years of age, was diagnosed with grand mal convulsion and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: anorexia, fatigue, irritability, unintended pregnancy. KEPPRA dosage: 1250 MG/D. Patient recovered.

KEPPRA problem was reported by a Physician from UNITED STATES on Mar 02, 2007. Female patient, 36 years of age, was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: pancytopenia. KEPPRA dosage: unknown. During the same period patient was treated with DEPAKOTE. Patient recovered.

Consumer or non-health professional from SWITZERLAND reported KEPPRA problem on Mar 01, 2007. Male patient, 42 years of age, weighting 132.3 lb, was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: hallucination, paranoia, treatment noncompliance. KEPPRA dosage: 500 MG 2/D; PO. During the same period patient was treated with TEMESTA, PRAZINE, SUBUTEX, DORMICUM, ROHYPNOL, LISITRIL, METOPROLOL SUCCINATE. Patient recovered.

KEPPRA problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 02, 2007. Female patient, 52 years of age, was diagnosed with epilepsy, urinary tract infection and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: convulsion, dehydration, fall, hypersensitivity, hypotension, infection, rash, traumatic brain injury. KEPPRA dosage: 1500 MG 2/D PO. During the same period patient was treated with LEVAQUIN, DILANTIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported KEPPRA problem on Mar 02, 2007. Female patient, 52 years of age, was diagnosed with epilepsy, urinary tract infection and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: convulsion, dehydration, fall, hypersensitivity, hypotension, traumatic brain injury, underdose, urinary tract infection. KEPPRA dosage: 1500 MG 2/D PO. During the same period patient was treated with LEVAQUIN, DILANTIN. Patient was hospitalized. Patient recovered.

KEPPRA problem was reported by a Physician from UNITED STATES on Mar 05, 2007. Male patient, weighting 16.73 lb, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: ventricular septal defect. KEPPRA dosage: 1500 MG TRP. During the same period patient was treated with FOLIC ACID, PRENATAL VITAMINS. Patient recovered.

Consumer or non-health professional from ITALY reported KEPPRA problem on Mar 05, 2007. Female patient, 59 years of age, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: bone marrow failure. KEPPRA dosage: 500 MG /D PO. During the same period patient was treated with TEGRETOL. Patient recovered.

KEPPRA problem was reported by a Consumer or non-health professional from GERMANY on Mar 05, 2007. Female patient, 38 years of age, was diagnosed with epilepsy, spondyloarthropathy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: aplastic anaemia, bone marrow failure, convulsion, leukopenia. KEPPRA dosage: unknown. During the same period patient was treated with CARBAMAZEPINE, AZULFIDINE, NAPROXEN. Patient was hospitalized. Patient recovered.

Physician from TURKEY reported KEPPRA problem on Mar 05, 2007. Male patient, 31 years of age, weighting 103.6 lb, was diagnosed with dysphemia, epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, anger, anxiety, self injurious behaviour. KEPPRA dosage: 250 MG 2/D PO. During the same period patient was treated with FRISIUM. Patient recovered.

KEPPRA problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 05, 2007. Male patient, 35 years of age, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: condition aggravated, epilepsy. KEPPRA dosage: 250 MG 3/D. During the same period patient was treated with LAMOTRIGINE, CARBAMAZEPINE. Patient recovered.

Consumer or non-health professional from FRANCE reported KEPPRA problem on Mar 08, 2007. Female patient, 74 years of age, weighting 123.5 lb, was diagnosed with epilepsy, pain and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: anorexia, asthenia, delirium, hallucination, loss of consciousness, pulmonary embolism, somnolence. KEPPRA dosage: 500 MG 2/D PO. During the same period patient was treated with NEURONTIN, ARIMIDEX, EZETROL, METOPROLOL TARTRATE, KARDEGIC, INIPOMP. Patient was hospitalized. Patient recovered.

KEPPRA problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 06, 2007. Female patient, 73 years of age, was diagnosed with convulsion and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: condition aggravated, convulsion, coronary artery disease, dementia, dyskinesia, encephalopathy, hallucination, visual. KEPPRA dosage: unknown. During the same period patient was treated with A BLOOD PRESSURE MED. Patient was hospitalized. Patient died on 11/14/2006.

Consumer or non-health professional from ITALY reported KEPPRA problem on Mar 06, 2007. Female patient, 63 years of age, was diagnosed with partial seizures and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: hepatitis acute, hepatorenal failure. KEPPRA dosage: 500 MG /D PO. During the same period patient was treated with DESAMETASONE, WARFARIN, OMEPRAZOLE, OFFICINAL PLANT, HOMEOPATIC PREPARATIONS, FOOD SUPPLEMENTS. Patient was hospitalized. Patient died on 07/28/2006.

KEPPRA problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 07, 2007. Female patient was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: trisomy 18. KEPPRA dosage: 1750 MG TRP. Patient died on 02/21/2007.

Consumer or non-health professional from UNITED STATES reported KEPPRA problem on Mar 07, 2007. Female patient, 37 years of age, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: biopsy chorionic villous abnormal, foetal disorder, trisomy 18, twin pregnancy. KEPPRA dosage: 1750 MG/D PO. During the same period patient was treated with PHENOBARBITAL, PRENATAL VITAMINS, FOLIC ACID. Patient recovered.

KEPPRA problem was reported by a Consumer or non-health professional from NETHERLANDS on Mar 07, 2007. Male patient, 81 years of age, was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: dehydration, liver disorder, renal disorder. KEPPRA dosage: 250 MG 2/D. During the same period patient was treated with TILDIEM, FUROSEMIDE, THYRAX, CARDIO PCH, CARBAMAZEPINUM RETARD, DIPHANTOINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from NETHERLANDS reported KEPPRA problem on Mar 07, 2007. Male patient, 81 years of age, was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: dehydration, liver disorder, renal disorder. KEPPRA dosage: 250 MG 2/D. During the same period patient was treated with TILDIEM, FUROSEMIDE GF, THYRAX, CARDIO PCH, CARBAMAZEPINUM RETARD, DIPHANTOINE Z. Patient was hospitalized. Patient recovered.

KEPPRA problem was reported by a Consumer or non-health professional from GERMANY on Mar 09, 2007. Female patient, 51 years of age, weighting 116.8 lb, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, condition aggravated, lymphocyte percentage decreased, red blood cell count decreased, white blood cell count decreased. KEPPRA dosage: 500 MG 4/D PO. During the same period patient was treated with DOXYCYCLIN, LEVOTHYROXINE, NEXIUM, KALINOR. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from FRANCE reported KEPPRA problem on Mar 08, 2007. Male patient, 68 years of age, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: haematuria, heparin-induced thrombocytopenia, hypothermia, pancytopenia. KEPPRA dosage: 1500 MG /D PO. During the same period patient was treated with AXEPIM, BIONOLYTE, DEROXAT, OMEPRAZOLE, TEMODAL, LOVENOX. Patient was hospitalized. Patient recovered.

KEPPRA problem was reported by a Consumer or non-health professional from FRANCE on Mar 08, 2007. Female patient, 72 years of age, weighting 161.6 lb, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: joint sprain, pancytopenia. KEPPRA dosage: 500 MG 2/D PO. During the same period patient was treated with DEPAKENE, TEMESTA, BI PREDONIUM, ZYRTEC, SEROPRAM. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported KEPPRA problem on Mar 08, 2007. Female patient, 26 years of age, was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. KEPPRA dosage: 200 MG/D. Patient recovered.

KEPPRA problem was reported by a Pharmacist from UNITED STATES on Mar 28, 2007. Female patient, 45 years of age, weighting 126.0 lb, was diagnosed with convulsion and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: neutrophil count decreased, white blood cell count decreased. KEPPRA dosage: unknown. Patient recovered.

Health Professional from GERMANY reported KEPPRA problem on Mar 13, 2007. Female patient was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: rash, status epilepticus. KEPPRA dosage: 500 MG 2/D. During the same period patient was treated with LAMOTRIGINE, LYRICA. Patient was hospitalized. Patient recovered.

KEPPRA problem was reported by a Physician from GERMANY on Mar 12, 2007. Female patient was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, grand mal convulsion, hallucination, visual, visual disturbance. KEPPRA dosage: 2500 MG /D PO. During the same period patient was treated with ERGENYL CHRONO, VALPROATE CHRONO, TOPIRAMATE, DOCITON, ENALAPRIL MALEATE, HUMINSULIN NORMAL. Patient recovered.

Physician from GERMANY reported KEPPRA problem on Mar 12, 2007. Female patient, 80 years of age, weighting 165.3 lb, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, weight increased. KEPPRA dosage: 250 MG /D PO. During the same period patient was treated with CARBAMAZEPINE, ASPIRIN. Patient died on 09/09/2006.

KEPPRA problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 14, 2007. Female patient, 75 years of age, was diagnosed with convulsion, neoplasm malignant and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: balance disorder, convulsion, fatigue, platelet count decreased, somnolence. KEPPRA dosage: 750 MG 2/D PO. During the same period patient was treated with TEMODAR, STEROIDS. Patient recovered.

Physician from GERMANY reported KEPPRA problem on Mar 14, 2007. Male patient, 17 years of age, was diagnosed with complex partial seizures, grand mal convulsion and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: aggression. KEPPRA dosage: 1500 MG 2/D PO. Patient was hospitalized. Patient recovered.

KEPPRA problem was reported by a Consumer or non-health professional from GERMANY on Mar 13, 2007. Male patient was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: jealous delusion. KEPPRA dosage: 500 MG 2/D. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported KEPPRA problem on Jan 18, 2007. Female patient, weighting 17.86 lb, was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: acrochordon. KEPPRA dosage: unknown. During the same period patient was treated with VITAMINS, RHOGAM. Patient recovered.

KEPPRA problem was reported by a Physician from UNITED STATES on Jan 26, 2007. Female patient, weighting 17.86 lb, was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: acrochordon. KEPPRA dosage: unknown. During the same period patient was treated with VITAMINS NOS, RHOGAM. Patient recovered.

Physician from UNITED STATES reported KEPPRA problem on Apr 03, 2007. Female patient, child 4 years of age, weighting 39.68 lb, was diagnosed with convulsion and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, agitation, hostility, psychotic disorder. KEPPRA dosage: 200MG BID PO. Patient recovered.

Showing 1-75 of 688 Next >

Ask Our Patient Community about KEPPRA
Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions
A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z
This drug has an active FDA Safety Alert
A Abacavir sulfate Abatacept Abilify Acamprosate calcium Accupril Accutane Aceon Aciphex Actiq (fentanyl citrate) Actimmune (aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b) Actonel (risedronate) Actoplus Met (pioglitazone) Actos (pioglitazone) AcuTect (technetium Tc 99m apcitide) Adefovir dipivoxil Advair Diskus(Fluticasone propionate; Salmeterol xinafoate) Adderall (amphetamine salts) Agenerase (amprenavir) Aggrastat (tirofiban) Alamast (pemirolast) Alendronate Alemtuzumab Aleve (naproxen sodium) Alfuzosin Alinia (nitazoxanide) Alimta (pemetrexed) Alitretinoin Almotriptan malate Alosetron hydrochloride Aloxi (palonosetron) Alrex (loteprednol etabonate) Altace (ramipril) Ambien (zolpidem tartrate) Amerge (naratriptan) Aminolevulinic acid Amiodarone Amitiza (lubiprostone) Amnesteem (isotretinoin) Amphadase (hyaluronidase) luronidase) Amphetamine salts Amprenavir Anaprox (naproxen sodium) Angiomax (bivalirudin) Anidulafungin Antagon (ganirelix acetate) Anthelios SX (avobenzone, ecamsule, octocrylene) Apidra (insulin glulisine recombinant) Apokyn (apomorphine) Aprepitant Aprotinin Aptivus (tipranavir) Aranesp (darbepoetin alpha) Arava (leflunomide) Arformoterol Argatroban Aredia (pamidronate) Aripiprazole Arixtra (fondaparinux) Aromasin (exemestane) Arranon (nelarabine) Arsenic trioxide Aspirin Atacand (candesartan cilexetil) Atazanavir sulfate Atomoxetine Avastin (bevacizumab) Avelox (moxifloxacin) Avobenzone, Ecamsule, Octocrylene Avodart (dutasteride) Avonex (interferon beta-1a) Axert (almotriptan malate) Azacitidine Azilect (rasagiline) Azopt (brinzolamide) back to top B Balsalazide disodium Baraclude (entecavir) Benazepril Benicar (olmesartan medoxomil) Bevacizumab Bexarotene Bextra (valdecoxib) Biaxin (clarithromycin) Bimatoprost Bivalirudin Boniva (ibandronate) Bortezomib Brinzolamide Brovana (arformoterol) Bupropion Butisol sodium Byetta (exenatide) back to top C Calfactant Campath (alemtuzumab) Campral (acamprosate calcium) Cancidas (caspofungin) Candesartan cilexetil Capecitabine Capoten (captopril) Captopril Carbamazepine Carbatrol (carbamazepine) Carbrital (pentobarbital and carbromal) Caspofungin Cefditoren pivoxil Cefepime Ceftriaxone Celebrex (celecoxib) Celecoxib Celexa (citalopram hydrobromide) Cetrorelix acetate Cetrotide (cetrorelix acetate) Cetuximab Cevimeline Chantix (varenicline) Cialis (tadalafil) Cilostazol Cinacalcet Cirlesonide Citalopram Claravis (isotretinoin) Clarithromycin Clarinex (desloratadine) Clolar (clofarabine) Clofarabine Clozapine Clozaril (clozapine) Codeine Colazal (balsalazide disodium) Colesevelam Colistimethate Coly-Mycin M (colistimethate) Comtan (entacapone) Concerta (methylphenidate) Conivaptan Cordarone (amiodarone) Crestor (rosuvastatin calcium) Cubicin (daptomycin) Curosurf (poractant alfa) Cylert (pemoline) Cymbalta (duloxetine) Cytotec (misoprostol) back to top D Dacogen (decitabine) Dalfopristin Dalmane (flurazepam) Daptomycin Darbepoetin alpha Darifenacin Darunavir Dasatinib Daytrana (methylphenidate transdermal) DDAVP (desmopressin) DDAVP Nasal Spray (demopressin) DDAVP Rhinal Tube (desmopressin) DDVP (desmopressin Decitabine Deferasirox Definity (perflutren lipid microspheres) Depacon (valproate) Depakene (valproate) Depakote (valproate) Desloratadine Desmopressin Detrol (tolterodine tartrate) terodine tartrate) Dexedrine (dextroamphetamine sulfate) Dexmedetomidine Dexmethylphenidate HCl > Dextroamphetamine sulfate Diastat AcuDial Diazepam rectal gel Didronel (etidronate) Diprivan (propofol) Dofetilide Doral (quazepam) Doxercalcif Drospirenone Duloxetine Duragesic (fentanyl transdermal system) Dutasteride back to top E Eculizumab Edetate disodium Efalizumab Efavirenz Effexor (venlafaxine) Elestat (epinastine) Eletriptan Elidel (pimecrolimus) Ellence (epirubicin) Eloxatin (oxaliplatin) Emend (aprepitant) Emtricitabine Emtriva (emtricitabine) Enablex (darifenacin) Enalapril / Enalaprilat Endrate (edetate disodium) Enfuvirtide Entacapone Entecavir Epinastine Epirubicin Eplerenone Epoetin alfa Epogen (epoetin alfa) Eptifibatide Equetro (carbamazepine) Eraxis (anidulafungin) Erbitux (cetuximab) Ertaczo (sertaconazole) Escitalopram Estazolam Eszopiclone Ethchlorvynol Ethinyl estradiol Etidronate Evoxac (cevimeline) Exelon (rivastigmine tartrate) Exenatide Exjade (deferasirox) Exemestane Extraneal (icodextrin) Ezetimibe Ezetimibe/simvastatin back to top	F Factive (gemifloxacin mesylate) Faslodex (fulvestrant) Felbamate Felbatol (felbamate) Fentanyl buccal tablets Fentanyl citrate Fentanyl transdermal system Fentora (fentanyl buccal tablets) Ferrlecit (sodium ferric gluconate complex) Fleet Accu-Prep (sodium phosphate) Fleet Phospho-Soda (sodium phosphate) Fluoxetine Flurazepam Fluticasone propionate Fluvoxamine Focalin (dexmethylphenidate) Focalin XR (dexmethylphenidate) Fomivirsen Fondaparinux Foradil (formoterol fumarate) Formoterol fumarate Fosamax (alendronate) Fosinopril Frova (frovatriptan succinate) Frovatriptan succinate Fulvestrant Fuzeon (enfuvirtide) G Gabapentin Gabitril (tiagabine) Gadobenate Dimeglumine Gadodiamide Gadolinium Gadopentetate Dimeglumine Gadoteridol Gadoversetamide Galantamine Ganirelix acetate Gatifloxacin Gefitinib Gemifloxacin mesylate Gemtuzumab ozogamicin Geodon (ziprasidone) Gleevec (imatinib mesylate) back to top H Halcion (triazolam) Haldol (haloperidol) Haloperidol Hectorol (doxercalcif) Hepsera (adefovir dipivoxil) Hyaluronidase Hydase (hyaluronidase) Human Secretin back to top I Ibandronate Ibuprofen Icodextrin Iloprost Imatinib mesylate Increlex (Mecasermin [rDNA origin] Infasurf Preservative Free (calfactant) Imitrex (sumatriptan) Innohep (tinzaparin) Inspra (eplerenone) Insulin Aspart recombinant Insulin Detemir recombinant Insulin Glargine recombinant Insulin Glulisine recombinant Intron A (interferon alfa-2b) Integrilin (eptifibatide) ifibatide) Interferon alfa-2b Interferon beta-1a Interferon gamma-1b Invega (paliperidone) Iplex  (mecasermin rinfabate) Iressa (gefitinib) Isotretinoin back to top J Januvia (sitagliptin phosphate) back to top K Kaletra (lopinavir; ritonavir) Kepivance (palifermin) Keppra (levetiracetam) Ketek (telithromycin) Ketotifen fumarate back to top L Lamictal (lamotrigine) Lamotrigine Lantus (insulin glargine recombinant) Leflunomide Lenalidomide Lepirudin recombinant Levalbuterol Levemir (insulin detemir recombinant) Levetiracetam Levitra (vardenafil) Levonorgestrel Levothyroxine sodium Levulan Kerastick (aminolevulinic acid) Lexapro (escitalopram) Lindane Linezolid Lisinopril Lopinavir/ritonavir Lotemax (loteprednol etabonate) Lotensin (benazepril) Loteprednol etabonate Lotronex (alosetron hydrochloride) Lubiprostone Lucentis (ranibizumab) Lumigan (bimatoprost) Lunestra (eszopiclone) Lyrica (pregabalin) back to top M Macugen (pegaptanib) Magnevist (gadopentetate dimeglumine) Maraviroc Mavik (trandolapril) Maxalt (rizatriptan benzoate) Maxipime (cefepime) Mecasermin [rDNA origin] Mecasermin-rinfabate Meloxicam Memantine Metadate CD (methylphenidate HCl) ylphenidate HCl) Methylphenidate HCl Methylphenidate transdermal Mequinol Micafungin Micardis (telmisartan) misartan) Mifeprex (mifepristone) Mifepristone Miglustat Minirin (desmopressin) Mirtazapine Misoprostol Mobic (meloxicam) Modafinil Moexipril Monopril (fosinopril) Moxifloxacin MultiHance (gadobenate dimeglumine) Mycamine (micafungin) Mylotarg (gemtuzumab ozogamicin) back to top N Namenda (memantine) Naprosyn (naproxen) Naproxen Naratriptan Nesiritide recombinant Nateglinide Natrecor (nesiritide recombinant) Nefazodone Nelarabine NeoTect Kit (technetium Tc 99m depreotide) Nesiritide recombinant Neurontin (gabapentin) Nexavar (sorafenib) Nitazoxanide Nitisinone Norelgestromin NovoLog (insulin aspart recombinant) Noxafil (posaconazole) back to top O Olanzapine Olanzapine/fluoxetine Olmesartan medoxomil Omacor (omega-3-acid ethyl esters) Omalizumab Omega-3-acid ethyl esters Omnaris (cirlesonide) Omniscan (gadodiamide) OptiMARK (gadoversetamide) Optison (perflutren protein-type A microspheres) Orencia (abatacept) Orfadin (nitisinone) Orlistat Ortho Evra (norelgestromin; ethinyl estradiol) Oseltamivir phosphate Osmoprep (sodium phosphate) Oxaliplatin Oxcarbazepine back to top P Pacerone (amiodarone) Palifermin Paliperidone Pamidronate Panitumumab Panretin Gel (alitretinoin) Pantoprazole Paricalcitol Paroxetine Paxil (paroxetine) Pegaptanib Pegvisomant Pemetrexed Pemoline Pentobarbital and carbromal Perflutren lipid microspheres Perindopril Phenergan (promethazine) Pimecrolimus Pioglitazone